Skip to content

Health Promotion for Women With Fibromyalgia

Health Promotion for Women With Fibromyalgia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00596674
Enrollment
177
Registered
2008-01-17
Start date
2003-07-31
Completion date
2008-05-31
Last updated
2012-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Women, Fibromyalgia Syndrome, Health Behaviors, Quality of Life

Brief summary

Women with chronic disabling conditions such as fibromyalgia syndrome (FMS) must manage a wide variety of disease-related, intrapersonal, and environmental demands to maintain their health and quality of life. Engaging in health-promoting behaviors is one strategy recommended to manage disease symptoms and enhance quality of life (USDHHS, 2000). The purpose of this four-year study is to refine and test a theoretically and empirically based intervention to promote the health and well being of women with the chronic disabling condition of fibromyalgia. We hypothesize that women who participate in the Lifestyle Counts Intervention will report more greater self-efficacy for health behaviors, more frequent health behaviors and more positive health and quality of life than women in the comparison group.

Detailed description

This wellness intervention, originally developed and tested in a randomized clinical trial of women with MS (N=113), resulted in significant improvements in self-efficacy, health behaviors and improvements in pain, social functioning, mental health and emotional role-functioning. The specific aims of this study are to examine the effects of the adapted wellness intervention on self-efficacy, resources, barriers, health behaviors and health outcomes for women with fibromyalgia. A sample of 160 women with FMS will be recruited to participate in a randomized clinical study to determine the effects of this wellness intervention that includes an eight week health promotion/behavior change component and 3 months of follow-up phone support. Content regarding stress management, lifestyle adjustment, physical activity, nutrition and women's health issues will be presented with an emphasis on the unique adaptations and associated skills required to empower women with the tools for exercising personal control over their health behaviors. The effects of the intervention on outcome variables will be assessed over an 8-month period with measurements at baseline, 2 months (immediately after the educational/skill-building component), 5 months (after 3 months of phone support) and at 8 months.

Interventions

BEHAVIORALLifestyle Counts

8 weeks of classes focused on health behavior change, individualized goal setting and 3 months of follow-up phone support

OTHERAttention Control

8 weeks of classes on general health information topics followed by 3 months of phone calls to solicit questions

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Female * Physician verified diagnosis of Fibromyalgia for at least 6 months, age 18 to 75, * Able to speak and read English * Willing to participate in 8-month intervention study

Exclusion criteria

* Pregnancy * Male * Concurrent medical conditions (as judged by their physician) for which changes in diet and exercise would be contraindicated

Design outcomes

Primary

MeasureTime frame
SF36 SubscalesBaseline, 2 months, 5 months and 8 months

Secondary

MeasureTime frame
Fibromyalgia Impact QuestionnaireBaseline, 2 months, 5 months, 8 months
Health Behaviors - The Health Promoting Lifestyle QuestionnaireBaseline, 2 months, 5 months 8 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026